CD70 and neoplasm: On the other hand, CD70-CAR-IL-15 NK cells induced a significant decrease in tumor burden compared to MOCK NK cells and a trend compared to conventional CD70-CAR NK cells over time (*significant on days 20, 21 and 22 post-treatment; Fig. 4C).